SY
SYBX.US Synlogic Inc
- Market cap
- USD 13.5M
- P/E
- -
- P/B
- 1.12x
- ROE
- -48.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is SYBX.US undervalued?
Graham numberThe Graham number of Synlogic Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Synlogic Inc fundamental analysis
No fundamental analysis for Synlogic Inc yet.
Synlogic Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Synlogic Inc
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
Full company profileSynlogic Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Synlogic Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 444K | 2.44M | 2.52M | 2.22M | 545K | 1.75M | 1.18M | 3.37M | 8.00K | 0.00 | - |
| Gross Profit | 285K | 2.44M | 2.52M | 2.22M | 545K | 1.75M | 1.18M | 3.37M | 8.00K | - | - |
| Operating Income | -26.6M | -40.8M | -51.2M | -54.4M | -60.5M | -60.8M | -67.4M | -55.2M | -41.0M | -4.01M | -3.81M |
| EBITDA | -25.2M | -38.5M | -48.8M | -51.7M | -57.8M | -58.3M | -63.6M | -55.3M | -23.0M | -3.53M | -5.67M |
| Net Income | -26.3M | -40.4M | -48.4M | -48.7M | -56.5M | -58.1M | -66.1M | -57.3M | -23.4M | -1.01M | -4.98M |
| EPS | -8.83 | -90 | -30 | -24 | -24 | -16 | -14 | -8.81 | -1.92 | -0.08 | -0.40 |
| Balance Sheet | |||||||||||
| Total Assets | 64.2M | 99.7M | 140M | 189M | 144M | 175M | 111M | 75.6M | 19.8M | 15.4M | 11.8M |
| Total Liabilities | 3.81M | 14.7M | 16.2M | 31.7M | 28.7M | 27.5M | 28.3M | 32.9M | 7.08M | 3.58M | 1.67M |
| Shareholders' Equity | 60.4M | 85.0M | 124M | 157M | 115M | 147M | 82.6M | 42.7M | 12.8M | 11.9M | 10.2M |
| Cash & Short-term Investments | 60.5M | 87.0M | 123M | 120M | 100M | 129M | 77.6M | 47.7M | 18.9M | 14.7M | 11.6M |
| Total Debt | 1.05M | 891K | 476K | 25.0M | 22.8M | 20.6M | 20.3M | 17.3M | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -24.8M | -31.1M | -42.5M | -75.5M | -39.6M | -52.2M | -56.9M | -51.6M | -31.7M | -4.36M | -4.15M |
| Capital Expenditure | 1.73M | 2.58M | 5.65M | 1.25M | 395K | 679K | 728K | 214K | 14.0K | 0.00 | 0.00 |
| Free Cash Flow | -26.5M | -33.6M | -48.1M | -76.7M | -39.9M | -52.9M | -57.6M | -51.8M | -31.7M | -4.36M | -4.15M |
| Ratios | |||||||||||
| ROE | -43.5% | -47.5% | -39.0% | -31.0% | -49.1% | -39.5% | -80.1% | -134.3% | -183.2% | -8.5% | -48.9% |
| ROA | -40.9% | -40.5% | -34.5% | -25.8% | -39.3% | -33.3% | -59.7% | -75.8% | -117.8% | -6.5% | -42.0% |
| Net Profit Margin | -5,916.2% | -1,652.1% | -1,922.0% | -2,188.4% | -10,373.8% | -3,313.5% | -5,605.7% | -1,699.3% | -291,987.5% | - | - |
| Debt to Equity | 0.02x | 0.01x | 0.00x | 0.16x | 0.20x | 0.14x | 0.25x | 0.40x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Synlogic Inc dividends
Synlogic Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:7 on Aug 28, 2017.
Who owns Synlogic Inc
- Insiders 15.65%
- Institutions 57.56%
- Public & others 26.80%
- Shares outstanding 12.2M
- Free float 4.03M
Top funds holding SYBX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Pacific Select Large-Cap Growth I | 5.32K | 0.04% | 0.00% | Aug 2026 |
| Extended Equity Market Fund B | 2.56K | 0.02% | 0.00% | Dec 2025 |
| Extended Equity Market Fund E | 2.56K | 0.02% | 0.00% | Dec 2025 |
Top institutions holding SYBX.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| DRW Securities, LLC | 23.8K | 0.20% | -2.46% | Mar 2026 |
| State Street Corp | 0.00 | 0.00% | -100.00% | Mar 2026 |
| Ikarian Capital, LLC | 0.00 | 0.00% | -100.00% | Mar 2026 |
| Susquehanna International Group, LLP | 0.00 | 0.00% | -100.00% | Mar 2026 |
| BlackRock Inc | 0.00 | 0.00% | -100.00% | Mar 2026 |
| Jane Street Group LLC | 0.00 | 0.00% | -100.00% | Mar 2026 |
| Northern Trust Corp | 0.00 | 0.00% | -100.00% | Mar 2026 |
| FMR Inc | 0.00 | 0.00% | -100.00% | Mar 2026 |
| FLAGSHIP HARBOR ADVISORS, LLC | 0.00 | 0.00% | -100.00% | Mar 2026 |
| Citigroup Inc | 0.00 | 0.00% | -100.00% | Mar 2026 |
| Citadel Advisors Llc | 0.00 | 0.00% | -100.00% | Mar 2026 |
| UBS Group AG | 0.00 | 0.00% | -100.00% | Mar 2026 |
| Danske Bank A/S. | 0.00 | 0.00% | -100.00% | Mar 2026 |
| Renaissance Technologies Corp | 0.00 | 0.00% | -100.00% | Mar 2026 |
| BNP Paribas Arbitrage, SA | 0.00 | 0.00% | -100.00% | Mar 2026 |
| Morgan Stanley - Brokerage Accounts | 0.00 | 0.00% | -100.00% | Mar 2026 |
| Geode Capital Management, LLC | 0.00 | 0.00% | -100.00% | Mar 2026 |
| JPMorgan Chase & Co | 0.00 | 0.00% | -100.00% | Mar 2026 |
| Cable Car Capital LLC | 0.00 | 0.00% | -100.00% | Mar 2026 |
| NEA Management Company, LLC | 0.00 | 0.00% | -100.00% | Mar 2026 |
Synlogic Inc company profile
- Company name
- Synlogic Inc
- Ticker
- SYBX.US
- Exchange
- USA Stocks
- Listed since
- Oct 1, 2015
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 1
- Fiscal year end
- December
- Address
- PO Box 30, Winchester, MA, United States, 01890
- Phone
- 617 659 2802
- Website
- synlogictx.com
About Synlogic Inc
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.
Synlogic Inc management
3- Ms. Mary Beth DooleyPrincipal Executive Officer & Principal Financial Officer · born 1982
- Dr. Timothy K. Lu M.D., Ph.D.Co-Founder & Member of Scientific Advisory Board · born 1981
- Dr. James J. Collins Ph.D.Co-Founder & Member of Scientific Advisory Board · born 1966